查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363214

乳癌诊断市场规模、份额、趋势分析报告：按产品、类型、用途、最终用途、地区和细分市场预测，2023-2030 年

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

乳癌诊断市场的成长与趋势：

Grand View Research, Inc. 的一项新研究显示，到 2030 年，全球乳癌诊断市场预计将达到 77 亿美元。

预计2023年至2030年该市场将以7.4%的年复合成长率扩张。这种增长主要是由于老龄化人口的乳癌风险增加和早期发现，以及乳癌意识的提高。

比 2D 乳房 X 光检查更准确的 3D 乳房 X 光检查和数数位乳房断层合成技术的推出正在支持市场成长。与 2D 乳房 X 光检查相比，这项先进技术可以检测出多 40.0% 的癌症，并减少患者召回。快速的技术进步是未来年度推动市场的主要要素。

公司正在采取策略来利用自家公司来开发新产品并加强供应链。 2019 年 11 月，Exact Sciences Corporation 宣布收购Genomic Health，收购该公司的产品系列预计将有助于加强其市场地位和服务产品。 2021 年 1 月，Hologic Inc. 宣布达成协议，以约 2.3 亿美元收购Biotheranostics。 Biotheranostics 是一家针对乳癌和转移性癌症的阶段分子诊断提供者。

由于乳癌预测和伴随诊断测试的不断推出，预计该市场将会成长。该领域最近推出的产品包括 Myriad Genetics 的 BRACAnalysis CDx，该产品于 2018 年获得 FDA核准作为乳癌伴随诊断。 2019 年 5 月，QIAGEN 宣布推出 therascreen PIK3CA RGQ PCR 试剂盒，作为诺华专有 PIQRAY 的伴随诊断，后者指南切片检查和液体切片检查的治疗决策。

2019 年 1 月，FUJIFILM Holdings公司宣布为 ASPIRE Cristalle 乳房 X 光摄影系统提供断层合成切片检查选项。该技术有望透过提供增强的 3D影像和数数位乳房 X 光检查，帮助医生比其他技术更有效地检测乳癌。

然而，这些影像检查具有独特的风险因素。它们涉及给药大量的萤光或钡显影剂，显影剂在影像成像和内视镜，还涉及辐射暴露，这可能会导致噁心和腹泻等多种副作用。与使用 CT、MRI 和 X 光以及在 PET 中使用放射性示踪剂注射相关的电离辐射暴露风险可能会限制此类筛检方法的采用。因此，影像的副作用等要素给该市场的企业带来了挑战。

乳癌诊断市场报告亮点

  • 预计影像领域在 2022 年占据最大的收益占有率，而血液领域预计将增长最快。
  • 按产品，由于美国、加拿大和美国等已开发国家对 45 岁以上女性进行强制筛检等政府配合措施，整体乳癌检查和筛检数量不断增加，基于设备的产品细分市场将在2022 年增长. 英国 ，2017年收益占有率占比最大。
  • 基于平台的产品领域预计将在预测期内呈现最快的成长。这些测试主要用于评估化疗和标靶治疗对女性的有效性。
  • 从用途来看，诊断和预测领域预计将在 2022 年占据市场主导地位，由于诊断学进步的合作研究和配合措施不断增加，预测领域预计将在预测期内呈现最快的年复合成长率。
  • 2022年，市场将由医院和诊所领域主导。
  • 由于 NGS 和 PCR 等基于平台的测试的兴起，预计医学实验室和诊断中心领域的复合年复合成长率将在预测期内实现最快。

目录

第1章调查方法与范围

第2章执行摘要

第3章乳癌诊断市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 乳癌诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章乳癌诊断：类型估计与趋势分析

  • 乳癌诊断市场的要点
  • 乳癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 影像
    • 2018年至2030年影像市场预测
  • 切片检查
    • 2018年至2030年切片检查市场估计与预测
  • 基因组测试
    • 2018年至2030年基因组检测市场估计与预测
  • 验血
    • 2018年至2030年血液检测市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第5章乳癌诊断：产品估算/趋势分析

  • 乳癌诊断市场的要点
  • 乳癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 基于平台的产品
  • 以仪器为基础的产品

第6章乳癌诊断：用途估计和趋势分析

  • 乳癌诊断市场的要点
  • 乳癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 筛选
    • 2018年至2030年筛选市场估计与预测
  • 诊断与预测
    • 2018 年至 2030 年诊断与预测市场估计与预测
  • 预后
    • 2018年至2030年的预测市场估计与预测
  • 调查
    • 研究2018年至2030年的市场估计与预测

第7章乳癌诊断：最终用途估计与趋势分析

  • 乳癌诊断市场的要点
  • 乳癌诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院和诊所
  • 诊断中心和医学实验室
  • 其他的

第8章乳癌诊断市场：按地区估计和趋势分析

  • 区域展望
  • 按地区分類的乳癌诊断市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Hologic Inc.
    • Genomic Health (Exact Sciences Corporation)
    • BD
    • Danaher
    • Koninklijke Philips NV
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Myriad Genetics, Inc.
    • Argon Medical Devices, Inc.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-3-68038-694-3

Breast Cancer Diagnostics Market Growth & Trends:

The global breast cancer diagnostics market size is expected to reach USD 7.7 billion by 2030, according to a new study by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.4% from 2023 to 2030. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company's market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

Breast Cancer Diagnostics Market Report Highlights:

  • The imaging segment held the largest revenue share in 2022 and the blood tests segment is expected to grow at the fastest rate
  • By product, the instrument-based products segment accounted for the largest revenue share in 2022 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer
  • The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women
  • By application, the diagnostic and predictive segment dominated the market in 2022 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics
  • The hospitals and clinics segment dominated the market in 2022
  • The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Application outlook
    • 2.2.4. End-use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Cancer Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Breast Cancer Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Breast Cancer Diagnostics: Type Estimates & Trend Analysis

  • 4.1. Breast Cancer Diagnostics Market, Key Takeaways
  • 4.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Imaging
    • 4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Biopsy
    • 4.4.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Genomic Tests
    • 4.5.1. Genomic tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Blood Tests
    • 4.6.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Breast Cancer Diagnostics: Product Estimates & Trend Analysis

  • 5.1. Breast Cancer Diagnostics Market, Key Takeaways
  • 5.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Platform-based Products
    • 5.3.1. Platform-based products market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.1. Next-generation sequencing
      • 5.3.1.1.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.2. Microarrays
      • 5.3.1.2.1. Microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.3. PCR
      • 5.3.1.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Instruments-based Products
    • 5.4.1. Instruments-based products market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.1.1. Imaging
      • 5.4.1.1.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.4.1.2. Biopsy
      • 5.4.1.2.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Breast Cancer Diagnostics: Application Estimates & Trend Analysis

  • 6.1. Breast Cancer Diagnostics Market, Key Takeaways
  • 6.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Screening
    • 6.3.1. Screening market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Diagnostic and Predictive
    • 6.4.1. Diagnostic and predictive market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Prognostic
    • 6.5.1. Prognostic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Research
    • 6.6.1. Research market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Breast Cancer Diagnostics: End-use Estimates & Trend Analysis

  • 7.1. Breast Cancer Diagnostics Market, Key Takeaways
  • 7.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Diagnostic Centers and Medical Laboratories
    • 7.4.1. Diagnostic centers and medical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Breast Cancer Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Breast Cancer Diagnostics Market by Region: Key Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Hologic Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Genomic Health (Exact Sciences Corporation)
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. BD
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Danaher
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Koninklijke Philips N.V.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. QIAGEN
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Thermo Fisher Scientific Inc.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Myriad Genetics, Inc.
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Argon Medical Devices, Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. F. Hoffmann-La Roche Ltd.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 12 Canada breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Germany breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Germany breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27 UK breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 France breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 France breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 France breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 31 France breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Spain breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Sweden breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 41 Sweden breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Norway breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 47 Norway breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Denmark breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Denmark breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 51 Denmark breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 57 Japan breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Japan breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 59 Japan breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Japan breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 China breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 62 China breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 China breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 64 China breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 India breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 66 India breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 India breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 68 India breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Australia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 70 Australia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 Australia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 72 Australia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Thailand breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 74 Thailand breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 Thailand breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 76 Thailand breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 South Korea breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 78 South Korea breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Korea breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Korea breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Latin America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 82 Latin America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Latin America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 84 Latin America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Latin America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 87 Brazil breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 88 Brazil breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Mexico breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 91 Mexico breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Mexico breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 93 Mexico breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Argentina breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 95 Argentina breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Argentina breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 South Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 108 South Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 110 South Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 UAE breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 112 UAE breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 UAE breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 Kuwait breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Breast cancer diagnostics: Market outlook
  • Fig. 9 Breast cancer diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Breast cancer diagnostics market driver impact
  • Fig. 15 Breast cancer diagnostics market restraint impact
  • Fig. 16 Breast cancer diagnostics strategic initiatives analysis
  • Fig. 17 Breast cancer diagnostics market: Type movement analysis
  • Fig. 18 Breast cancer diagnostics market: Type outlook and key takeaways
  • Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Genomic tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Breast cancer diagnostics market: Product movement analysis
  • Fig. 25 Breast cancer diagnostics market: Product outlook and key takeaways
  • Fig. 26 Platform based products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Instruments-based products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Breast cancer diagnostics market: Application movement analysis
  • Fig. 34 Breast cancer diagnostics market: Application outlook and key takeaways
  • Fig. 35 Screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Diagnostic and predictive market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Prognostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Breast cancer diagnostics market: End-use movement analysis
  • Fig. 40 Breast cancer diagnostics market: End-use outlook and key takeaways
  • Fig. 41 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Diagnostic centers and medical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global breast cancer diagnostics market: Regional movement analysis
  • Fig. 45 Global breast cancer diagnostics market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)